Aarti Pharmalabs Limited has filed a writ petition in the Gujarat High Court to contest a Rs 59.50 crore stamp duty and penalty demand issued by the Superintendent of Stamps. The dispute relates to a past demerger scheme sanctioned by the NCLT. Investors should note this potential financial liability as the company seeks legal relief against the regulatory order.
Aarti Pharmalabs Challenges Rs 59.50 Crore Stamp Duty Demand
Total liability: Rs 59.50 crore; Legal action: Writ Petition filed in Gujarat High Court.
Reader Takeaway: Company contests stamp duty order to protect cash reserves, awaiting judicial clarity on demerger liability.
What just happened
Aarti Pharmalabs Limited has moved the Hon'ble High Court of Gujarat at Ahmedabad, filing a writ petition against an order dated August 29, 2026. The order, issued by the Superintendent of Stamps in Gandhinagar, demands payment of Rs 59.50 crore in stamp duty and associated penalties.
Why this matters
The demand stems from a Scheme of Arrangement—a demerger—that was previously sanctioned by the NCLT, Ahmedabad Bench, on September 21, 2022. The company is actively challenging the validity of this additional duty levy. If the court ruling does not favor the company, it may face a significant cash outflow that could impact its financial position.
The backstory
The company previously disclosed the receipt of the Superintendent of Stamps' order on September 02, 2026. The current petition represents the formal legal escalation to protect the company’s interests against the state authority's assessment.
Risks to watch
The primary risk is the financial hit of Rs 59.50 crore. Legal proceedings are inherently uncertain, and there is no guarantee that the court will stay the order or rule in favor of the company. Investors should closely monitor upcoming quarterly disclosures for any mention of provisions made for this liability or updates on interim relief granted by the High Court.
What to track next
Watch for any subsequent orders from the Gujarat High Court and any formal communications regarding the stay of the current demand notice. Future regulatory filings will be key to understanding whether the company remains confident in its legal stance.